New drugs and product approvals from 2001.
Taylor
Samuel E
SE
Department of Oral & Maxillofacial Surgery & Pharmacology, Baylor College of Dentistry, Texas A&M University System Health Science Center, USA.
D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D001168:Arthritis / Q000188:drug therapy; D002317:Cardiovascular Agents / Q000627:therapeutic use; D002491:Central Nervous System Agents / Q000627:therapeutic use; D003278:Contraceptives, Oral, Hormonal / Q000627:therapeutic use; D017277:Drug Approval; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009883:Ophthalmic Solutions / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D018927:Anti-Asthmatic Agents; D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000935:Antifungal Agents; D000970:Antineoplastic Agents; D000998:Antiviral Agents; D002317:Cardiovascular Agents; D002491:Central Nervous System Agents; D003278:Contraceptives, Oral, Hormonal; D006634:Histamine H1 Antagonists; D007166:Immunosuppressive Agents; D009883:Ophthalmic Solutions